0310-0800 : Tudorza Pressair 400 ug/1 Respiratory (Inhalation) Inhalant


NDC0310-0800
Labeler: Astrazeneca Pharmaceuticals Lp
Product Type: Human Prescription Drug
Drug Name:  Tudorza Pressair
Dosage Form: Respiratory (Inhalation) Inhalant
Application #: NDA202450
Rev. Date: 


NDC Package Codes:

  • 0310-0800-39: 1 POUCH IN 1 CARTON (0310‑0800‑39) > 1 INHALER IN 1 POUCH > 30 INHALANT IN 1 INHALER
  • 0310-0800-60: 1 POUCH IN 1 CARTON (0310‑0800‑60) > 1 INHALER IN 1 POUCH > 60 INHALANT IN 1 INHALER
  • 0310-0800-95: 1 POUCH IN 1 CARTON (0310‑0800‑95) > 1 INHALER IN 1 POUCH > 30 INHALANT IN 1 INHALER

Active Ingredients:

  • Aclidinium Bromide

Dosage Strength:

  • 400 ug/1

Pharmaceutical Classes:

  • Anticholinergic [EPC]
  • Cholinergic Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 0456-0800 Tudorza Pressair 400 ug/1 Respiratory (Inhalation) Inhalant by Forest Laboratories, Inc.
  • 72124-002 Tudorza Pressair 400 ug/1 Respiratory (Inhalation) Inhalant by Circassia Pharmaceuticals Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0310-0800 QR Code

< Prev: 0310-0755Next: 0310-0950 >

Related Discussions:

Tudorza Pressair Coupon
I am looking for a coupon or discount to offset the amount that my health insurance does not cover ## As far as saving m... 1 reply
Has Anyone On Tudorza And Daliresp
Is anyone on the new inhaler Tudorza and a new drug for copd called Daliresp and have you had any problem s with either ... 3 replies
Tudorza pressair coverd by insurance
Is tudorza pressair covered by bcbsil, what is co pay?...
tudorza
difficult breathing in to turn the indicator red...




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.